<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00943046</url>
  </required_header>
  <id_info>
    <org_study_id>43-1</org_study_id>
    <nct_id>NCT00943046</nct_id>
  </id_info>
  <brief_title>Master Study for the Investigation of Safety and Efficacy of the SIELLO Pacemaker Leads</brief_title>
  <official_title>Master Study of the SIELLO Pacemaker Leads</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to prove the safety and efficacy of the SIELLO pacemaker
      leads.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The assessment of the safety of SIELLO pacemaker leads is based on the collection of
      complications which are related to the leads. The assessment of efficacy of the SIELLO
      pacemaker leads is based on the collection of standard electrical lead data during the
      implant and follow-up procedures. Subsequent to the implantation of the SIELLO leads,five
      follow-up visits have been scheduled: at pre-discharge and after 1, 3, 6 and 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complication free rate of all SIELLO leads</measure>
    <time_frame>3 month follow-up visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventricular threshold of SIELLO T (passive fixation)</measure>
    <time_frame>3 month follow-up visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Atrial threshold of SIELLO S (active fixation)</measure>
    <time_frame>3 month follow-up visits</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">164</enrollment>
  <condition>Cardiac Pacemaker Syndrome</condition>
  <arm_group>
    <arm_group_label>Siello pacemaker lead</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with Siello Pacemaker lead</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacemaker therapy</intervention_name>
    <description>Implantation of the SIELLO pacemaker leads</description>
    <arm_group_label>Siello pacemaker lead</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meet the indications for pacemaker therapy

          -  Understand the nature of the procedure

          -  Give informed consent

          -  Able to complete all testing required by the clinical protocol

          -  Available for follow-up visits on a regular basis at the investigational site

        Exclusion Criteria:

          -  Meet none of the pacemaker indications

          -  Meet one or more of the contraindications

          -  Have a life expectancy of less than six months

          -  Cardiac surgery in the next six months -Enrolled in another cardiac clinical
             investigation- Have other medical devices that may interact with the implanted
             pacemaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anselm Schaumann, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>n.k.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Hamburg Altona</name>
      <address>
        <city>Hamburg</city>
        <zip>22763</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>July 14, 2009</study_first_submitted>
  <study_first_submitted_qc>July 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2009</study_first_posted>
  <last_update_submitted>July 24, 2019</last_update_submitted>
  <last_update_submitted_qc>July 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>leads</keyword>
  <keyword>pacemaker</keyword>
  <keyword>efficacy</keyword>
  <keyword>safety</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

